Cargando…

Gene Therapy for Lung Diseases

Gene therapy is under development for a variety of lung disease, both those caused by single gene defects, such as cystic fibrosis and α(1)-antitrypsin deficiency, and multifactorial diseases such as cancer, asthma, lung fibrosis, and ARDS. Both viral and nonviral approaches have been explored, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alton, Eric W.F.W., Davies, Jane C., Geddes, Duncan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121178/ http://dx.doi.org/10.1007/978-1-59259-963-9_28

Ejemplares similares

Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
por: Ferrari, Stefano, et al.
Publicado: (2002)

Taking stock of gene therapy for cystic fibrosis
por: Stern, Myra, et al.
Publicado: (2000)

Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015)

Gene therapy for cystic fibrosis: an example for lung gene therapy
por: Griesenbach, U, et al.
Publicado: (2004)

Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
por: Griesenbach, Uta, et al.
Publicado: (2015)

Progress in Respiratory Gene Therapy
por: McLachlan, Gerry, et al.
Publicado: (2022)

Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis
por: Hollox, Edward J, et al.
Publicado: (2005)

Gene Therapy Progress and Prospects: Cystic fibrosis
por: Griesenbach, U, et al.
Publicado: (2002)

Hot topics in biomaterials
por: Alton, Eric W, et al.
Publicado: (2014)

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection
por: Martin, Isaac, et al.
Publicado: (2023)

Pseudomonas aeruginosa induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway
por: Coates, Matthew S., et al.
Publicado: (2021)

The Pathogenesis of Cystic Fibrosis and Progress Towards Gene Therapy
por: Stern, Myra, et al.
Publicado: (1999)

Variability in Bacteriophage and Antibiotic Sensitivity in Serial Pseudomonas aeruginosa Isolates from Cystic Fibrosis Airway Cultures over 12 Months
por: Martin, Isaac, et al.
Publicado: (2021)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
por: Lund-Palau, Helena, et al.
Publicado: (2022)

Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis
por: Turnbull, Andrew R., et al.
Publicado: (2020)

The history of respiratory disease management
por: Geddes, Duncan
Publicado: (2016)

The history of respiratory disease management
por: Geddes, Duncan
Publicado: (2020)

Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
por: Bierman, WFW, et al.
Publicado: (2010)

Nitrogen offset in N(2) multiple washout method
por: Bayfield, Katie J., et al.
Publicado: (2020)

Simultaneous sulfur hexafluoride and nitrogen multiple-breath washout (MBW) to examine inherent differences in MBW outcomes
por: Bayfield, Katie J., et al.
Publicado: (2019)

Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass Spectrometry
por: Bardin, Emmanuelle E., et al.
Publicado: (2018)

PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
por: Osman, Gizem, et al.
Publicado: (2018)

Gene therapy for cystic fibrosis lung disease
por: Sumner-Jones, Stephanie G., et al.
Publicado: (2011)

Gene therapy for the treatment of cystic fibrosis
por: Burney, Tabinda J, et al.
Publicado: (2012)

Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
por: Donnelley, Martin, et al.
Publicado: (2018)

Pulmonary Eosinophilia
por: Geddes, Duncan M.
Publicado: (1986)

Lung Collapse Therapy
por: Davies, H. Morriston
Publicado: (1933)

Rational Antibiotic Therapy
por: Geddes, A. M.
Publicado: (1980)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
por: Paul-Smith, Michael C., et al.
Publicado: (2018)

Curvilinearity provides additional information to lung clearance index only in a minority of children with early cystic fibrosis lung disease
por: Irving, Samantha, et al.
Publicado: (2022)

Additional Paleopathological Evidence of Paget’s Disease
por: Fisher, Alton K.
Publicado: (1935)

Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
por: Sepahzad, Afsoon, et al.
Publicado: (2021)

Comparison of the upper and lower airway microbiota in children with chronic lung diseases
por: Ahmed, Bushra, et al.
Publicado: (2018)

Bilateral Destructive Hip Disease from Untreated Juvenile Idiopathic Arthritis
por: Calafi, Arash, et al.
Publicado: (2019)

Gene therapy for acute lung injury
por: Brigham, K. L., et al.
Publicado: (2000)

Atmospheric Degradation of Cyclic Volatile Methyl Siloxanes: Radical Chemistry and Oxidation Products
por: Alton, Mitchell W., et al.
Publicado: (2022)

Delivering gene therapy for mucopolysaccharide diseases
por: Wood, Shaun R., et al.
Publicado: (2022)

EPS4.6 Inherent differences in multiple breath washout (MBW) using N(2) and SF(6) demonstrated by simultaneous analysis with respiratory mass spectrometry (RMS)
por: Bayfield, K.J., et al.
Publicado: (2017)

Gene Therapy for Occupational Lung Disease: Steering Macrophages in the Right Direction?
por: Remcho, T. Parks, et al.
Publicado: (2022)

A Modified Technique for Applying Closed Incision Negative Pressure Therapy Dressing Following Total Joint Arthroplasty
por: Dowling, Shane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tc87itcga3dvka6qm5c85hhigb